Search for Clinical Trial Results
Leukemia, Promyelocytic, Acute - 25 Studies Found
Status | Study |
Recruiting |
Study Name: Proteasome Inhibition in Acute Promyelocytic Leukemia Condition: Relapsed Acute Promyelocytic Leukemia Date: 2013-09-22 Interventions: Drug: Bortezomib Combination of arsenic trioxide with bortezomib in the treatment of relapsed acute prom |
Recruiting |
Study Name: Single Agent Arsenic Trioxide in the Treatment of Newly Diagnosed Acute Promyelocytic Leukemia Condition: Acute Promyelocytic Leukemia Date: 2007-08-16 Interventions: Drug: Single agent arsenic trioxide duration of maintenance therapy, 6 months versus 12 months |
Recruiting |
Study Name: Study of NRX 195183 Therapy for Patients With Relapsed or Refractory Acute Promyelocytic Leukemia Condition: Acute Promyelocytic Leukemia Date: 2008-05-07 Interventions: Drug: NRX 195183 Soft Gelatin Capsule Daily oral NRX 195183 administration for 90 days to assess CR rate |
Recruiting |
Study Name: Study for Patients With Newly Diagnosed, High-risk Acute Promyelocytic Leukemia Condition: Acute Promyelocytic Leukemia Date: 2016-02-11 Interventions:
|
Terminated |
Study Name: Tamibarotene and Arsenic Trioxide for Relapsed Acute Promyelocytic Leukemia Condition: Acute Promyelocytic Leukemia Date: 2009-09-25 Interventions:
|
Recruiting |
Study Name: French Registry of First-line Treatment of Acute Promyelocytic Leukemia Condition: Acute Promyelocytic Leukemia Date: 2016-09-22 |
Completed |
Study Name: Long-Term Quality of Life in Patients With Acute Promyelocytic Leukemia Condition: Acute Promyelocytic Leukemia Date: 2013-03-28 Interventions: Other: Health Related Quality of Life (HRQOL) measures Other Names:
|
Withdrawn |
Study Name: New Retinoid Agent Combined With Arsenic Trioxide for Untreated Acute Promyelocytic Leukemia Condition: Acute Promyelocytic Leukemia Date: 2008-04-28 Interventions:
|
Active, not recruiting |
Study Name: Combined Tretinoin and Arsenic Trioxide for Patients With Newly Diagnosed Acute Promyelocytic Leukemia Followed by Risk-Adapted Postremission Therapy Condition: Acute Promyelocytic Leukemia Date: 2011-07-27 Interventions: Drug: Tretinoin and Arsenic Trioxide See Detailed Description |
Recruiting |
Study Name: Role of Microparticles in the Coagulopathy of Acute Promyelocytic Leukemia Condition: Acute Promyelocytic Leukemia Date: 2016-03-02 |